| Overview |
| bs-4542R-Cy5 |
| BRLF1 Polyclonal Antibody, Cy5 Conjugated |
| WB |
| Human, Virus |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from Epstein-Barr virus Replication and transcription activator |
| 81-180/605 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3783727 |
| P03209 |
| Replication and transcription activator; Rta; Immediate-early protein Rta; BRLF1 |
| Immediate-early transcription factor that controls the initiation of viral lytic gene expression and lytic reactivation from latency. Triggers lytic replication, and initiates a cellular senescence program in epithelial cells. Upregulates human DCR3/TNFRSF6B by directly binding to its receptor. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz